In the absence of infection, VAN imparted no change in gene expression or NAD(P)H lifetime, while DAP and TED treatments affected only expression of selected KC genes but significantly reduced mean NAD(P)H lifetime toward a glycolytic trajectory. The gene discussed is CALCA; the disease is infection.